Autocrine feedback inhibition of plateau potentials terminates phasic bursts in magnocellular neurosecretory cells of the rat supraoptic nucleus

Journal of Physiology

Volumn 557, Issue 3, 2004, Pages 949-960

  Brown, Colin H ^a,b   Bourque, Charles W ^a  

^a MONTREAL GENERAL HOSPITAL   (Canada)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA LATROTOXIN; BINALTORPHIMINE; DYNORPHIN; KAPPA OPIATE RECEPTOR; KAPPA OPIATE RECEPTOR AGONIST; KAPPA OPIATE RECEPTOR ANTAGONIST; MU OPIATE RECEPTOR ANTAGONIST; OXYTOCIN; VASOPRESSIN; VASOPRESSIN RECEPTOR ANTAGONIST;

AFTERHYPERPOLARIZATION; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; AUTOCRINE EFFECT; CELL MEMBRANE DEPOLARIZATION; CELL VACUOLE; CONDITIONING; CONTROLLED STUDY; DENDRITE; DEPLETION; ELECTRODE; ENZYME INHIBITION; EXOCYTOSIS; EXPLANT; HYPOTHALAMUS; INTRACELLULAR RECORDING; MAGNOCELLULAR NUCLEUS; MALE; NEGATIVE FEEDBACK; NERVE CELL MEMBRANE POTENTIAL; NERVE ENDING; NEUROSECRETORY CELL; NONHUMAN; PRIORITY JOURNAL; RAT; SPIKE WAVE; SUPRAOPTIC NUCLEUS; TEMPORAL SUMMATION; CELL ACTIVITY; EVOKED RESPONSE; MAGNOCELLULAR NEUROSECRETORY CELL; NERVE CONDUCTION; NERVE POTENTIAL; PLATEAU POTENTIAL; PROTEIN LOCALIZATION; PROTEIN SECRETION; REGENERATIVE ABILITY;

3,4-DICHLORO-N-METHYL-N-(2-(1-PYRROLIDINYL)-CYCLOHEXYL)-BENZENEACETAMIDE, (TRANS)-ISOMER; ACTION POTENTIALS; ANIMALS; AUTOCRINE COMMUNICATION; CELL SIZE; DENDRITES; DYNORPHINS; ELECTRIC STIMULATION; ELECTROPHYSIOLOGY; FEEDBACK; MALE; MEMBRANE POTENTIALS; NERVE REGENERATION; NEUROSECRETORY SYSTEMS; PATCH-CLAMP TECHNIQUES; RATS; RATS, LONG-EVANS; RECEPTORS, OPIOID, KAPPA; SUPRAOPTIC NUCLEUS;

EID: 3242721424     PISSN: 00223751     EISSN: None     Source Type: Journal    
DOI: 10.1113/jphysiol.2004.063818     Document Type: Article

References (42)

1. Andrew RD (1987). Endogenous bursting by rat supraoptic neuroendocrine cells is calcium dependent. J Physiol 384, 451-465.
2. Andrew RD & Dudek FE (1983). Burst discharge in mammalian neuroendocrine cells involves an intrinsic regenerative mechanism. Science 221, 1050-1052.
3. Armstrong WE, Smith BN & Tian M (1994). Electrophysiological characteristics of immunochemically identified rat oxytocin and vasopressin neurones in vitro. J Physiol 475, 115-128.
4. Bourque CW (1986). Calcium-dependent spike after-current induces burst firing in magnocellular neurosecretory cells. Neurosci Lett 70, 204-209.
5. Brimble MJ & Dyball RE (1977). Characterization of the responses of oxytocin- and vasopressin-secreting neurones in the supraoptic nucleus to osmotic stimulation. J Physiol 271, 253-271.
6. Brown CH, Ghamari-Langroudi M, Leng G & Bourque CW (1999). Kappa-opioid receptor activation inhibits post-spike depolarizing after-potentials in rat supraoptic nucleus neurones in vitro. J Neuroendocrinol 11, 825-828.
7. Brown CH & Leng G (2000). In vivo modulation of post-spike excitability in vasopressin cells by kappa-opioid receptor activation. J Neuroendocrinol 12, 711-714.
8. Brown CH, Ludwig M & Leng G (1998). Kappa-opioid regulation of neuronal activity in the rat supraoptic nucleus in vivo. J Neurosci 18, 9480-9488.
9. Brown CH, Ludwig M & Leng G (2004). Temporal dissociation of the feedback effects of dendritically co-released peptides on rhythmogenesis in vasopressin cells. Neuroscience 124, 105-111.
10. Brown CH, Russell JA & Leng G (2000). Opioid modulation of magnocellular neurosecretory cell activity. Neurosci Res 36, 97-120.
11. Burbach JP, De Bree FM, Terwel D, Tan A, Maskova HP & Van Der Kleij AA (1993). Properties of aminopeptidase activity involved in the conversion of vasopressin by rat brain membranes. Peptides 14, 807-813.
12. Cross BA, Dyball RE, Dyer RG, Jones CW, Lincoln DW, Morris JF & Pickering BT (1975). Endocrine neurons. Recent Prog Horm Res 31, 243-294.
13. Ghamari-Langroudi M & Bourque CW (1998). Caesium blocks depolarizing after-potentials and phasic firing in rat supraoptic neurones. J Physiol 510, 165-175.
14. Greffrath W, Martin E, Reuss S & Boehmer G (1998). Components of after-hyperpolarization in magnocellular neurones of the rat supraoptic nucleus in vitro. J Physiol 513, 493-506.
15. Harris MC, Dreifuss JJ & Legros JJ (1975). Excitation of phasically firing supraoptic neurones during vasopressin release. Nature 258, 80-82.
16. Hawkins KN, Knapp RJ, Lui GK, Gulya K, Kazmierski W, Wan YP, Pelton JT, Hruby VJ & Yamamura HI (1989). [3H]-[H-D-Phe-Cys-Tyr-D-Trp-Orn-Thr-Pen-Thr-NH2] ([3H]CTOP), a potent and highly selective peptide for mu opioid receptors in rat brain. J Pharmacol Exp Ther 248, 73-80.
17. Hiranuma T, Kitamura K, Taniguchi T, Kanai M, Arai Y, Iwao K & Oka T (1998). Protection against dynorphin-(1-8) hydrolysis in membrane preparations by the combination of amastatin, captopril and phosphoramidon. J Pharmacol Exp Ther 286, 863-869.
18. Hlubek M, Tian D & Stuenkel EL (2003). Mechanism of alpha-latrotoxin action at nerve endings of neurohypophysis. Brain Res 992, 30-42.
19. Hurbin A, Orcel H, Alonso G, Moos F & Rabie A (2002). The vasopressin receptors colocalize with vasopressin in the magnocellular neurons of the rat supraoptic nucleus and are modulated by water balance. Endocrinology 143, 456-466.
20. Inenaga K, Nagatomo T, Nakao K, Yanaihara N & Yamashita H (1994). Kappa-selective agonists decrease postsynaptic potentials and calcium components of action potentials in the supraoptic nucleus of rat hypothalamus in vitro. Neuroscience 58, 331-340.
21. + current in rat supraoptic neurones in vitro. J Physiol 494, 389-398.
22. Kombian SB, Mouginot D & Pittman QJ (1997). Dendritically released peptides act as retrograde modulators of afferent excitation in the supraoptic nucleus in vitro. Neuron 19, 903-912.
23. Kruszynski M, Lammek B, Manning M, Seto J, Haldar J & Sawyer WH (1980). [1-beta-Mercapto-beta, beta-cyclopentamethylenepropionic acid),2-(O-methyl) tyrosine]argine-vasopressin and [1-beta-mercapto-beta, beta-cyclopentamethylenepropionic acid)] argine-vasopressin, two highly potent antagonists of the vasopressor response to arginine-vasopressin. J Med Chem 23, 364-368.
24. Leng G, Brown CH & Russell JA (1999). Physiological pathways regulating the activity of magnocellular neurosecretory cells. Prog Neurobiol 57, 625-655.
25. Leng G & Dyball RE (1983). Intercommunication in the rat supraoptic nucleus. Q J Exp Physiol 68, 493-504.
26. Li Z, Decavel C & Hatton GI (1995). Calbindin-D28k: role in determining intrinsically generated firing patterns in rat supraoptic neurones. J Physiol 488, 601-608.
27. 2+ release from internal stores: role in generating depolarizing after-potentials in rat supraoptic neurones. J Physiol 498, 339-350.
28. Li JG, Luo LY, Krupnick JG, Benovic JL & Liu-Chen LY (1999). U50,488H-induced internalization of the human kappa opioid receptor involves a beta-arrestin- and dynamin-dependent mechanism. Kappa receptor internalization is not required for mitogen-activated protein kinase activation. J Biol Chem 274, 12087-12094.
29. Ludwig M (1998). Dendritic release of vasopressin and oxytocin. J Neuroendocrinol 10, 881-895.
30. Ludwig M & Leng G (1997). Autoinhibition of supraoptic nucleus vasopressin neurons in vivo: a combined retrodialysis/electrophysiological study in rats. Eur J Neurosci 9, 2532-2540.
31. Mason WT, Cobbett P, Inenaga K & Legendre P (1988). Ionic currents in cultured supraoptic neurons: actions of peptides and transmitters. Brain Res Bull 20, 757-764.
32. + currents in magnocellular neurons of the supraoptic nucleus in rat. J Neurophysiol 81, 1617-1625.
33. Portoghese PS, Lipkowski AW & Takemori AE (1987). Binaltorphimine and nor-binaltorphimine, potent and selective kappa-opioid receptor antagonists. Life Sci 40, 1287-1292.
34. Pow DV & Morris JF (1989). Dendrites of hypothalamic magnocellular neurons release neurohypophysial peptides by exocytosis. Neuroscience 32, 435-439.
35. Renaud LP & Bourque CW (1991). Neurophysiology and neuropharmacology of hypothalamic magnocellular neurons secreting vasopressin and oxytocin. Prog Neurobiol 36, 131-169.
36. Rhodes CH, Morrell JI & Pfaff DW (1981). Immunohistochemical analysis of magnocellular elements in rat hypothalamus: distribution and numbers of cells containing neurophysin, oxytocin, and vasopressin. J Comp Neurol 198, 45-64.
37. Richard P, Moos F, Dayanithi G, Gouzenes L & Sabatier N (1997). Rhythmic activities of hypothalamic magnocellular neurons: autocontrol mechanisms. Biol Cell 89, 555-560.
38. Roper P, Armstrong WE & Callaway J (2004). Burst initiation and termination in phasic vasopressin cells of the rat SON: a combined mathematical, electrical and calcium fluorescence study. J Neurosci 24, 4818-4831.
39. Shuster SJ, Riedl M, Li X, Vulchanova L & Elde R (2000). The kappa opioid receptor and dynorphin co-localize in vasopressin magnocellular neurosecretory neurons in guinea-pig hypothalamus. Neuroscience 96, 373-383.
40. Ushkaryov Y (2002). Alpha-latrotoxin: from structure to some functions. Toxicon 40, 1-5.
41. Wakerly JB, Poulain DA, Dyball RE & Cross BA (1975). Activity of phasic neurosecretory cells during haemorrhage. Nature 258, 82-84.
42. Whitnall MH, Gainer H, Cox BM & Molineaux CJ (1983). Dynorphin-A-(1-8) is contained within vasopressin neurosecretory vesicles in rat pituitary. Science 222, 1137-1139.